These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8331496)

  • 1. Preparations of liposomal fluconazole and their in vitro antifungal activity.
    Singh M; Singh MP; Maiti SN; Gandhi A; Micetich RG; Atwal H
    J Microencapsul; 1993; 10(2):229-36. PubMed ID: 8331496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole.
    Mallié M; Montès B; Reynes J; Bastide JM
    Drugs Exp Clin Res; 1990; 16(10):509-13. PubMed ID: 2100733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro evaluation of the sensitivity to fluconazole of different species of yeasts isolated in pathology].
    Regli P; Blancard A; Goudard M; Moulin-Traffort J; Sarzier JM; Quilici M
    Pathol Biol (Paris); 1992 May; 40(5):500-6. PubMed ID: 1495834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
    Linares MJ; Charriel G; Solís F; Casal M
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
    Yücesoy M; Marol S
    Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of fluconazole against Candida albicans isolated from blood culture].
    Pemán J; Cantón E; Orero A; Ubeda P; Viudes A; Pastor A; Gobernado M
    Rev Esp Quimioter; 1998 Dec; 11(4):339-43. PubMed ID: 10336314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxylic acid and phosphate ester derivatives of fluconazole: synthesis and antifungal activities.
    Nam NH; Sardari S; Selecky M; Parang K
    Bioorg Med Chem; 2004 Dec; 12(23):6255-69. PubMed ID: 15519168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
    Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
    Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
    Bulatova NR; Darwish RM
    Med Princ Pract; 2008; 17(2):117-21. PubMed ID: 18287794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
    Tan GL; Peterson EM
    J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
    Seifert H; Aurbach U; Stefanik D; Cornely O
    Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening of Candida albicans fluconazole--resistant mutation strains].
    Wang W; Zhang B; Wang X; Liu Y; Wang D
    Wei Sheng Wu Xue Bao; 1997 Jun; 37(3):212-6. PubMed ID: 9863212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid identification of fluconazole resistance using Chromagar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
    Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
    Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
    Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.